FDA.reportPublic FDA data

Aspruzyo 1000 MG Oral Granules

RxCUI
2594759
RxNorm name
Aspruzyo 1000 MG Oral Granules
Display name
Aspruzyo 1000 MG Oral Granules
Full name
Aspruzyo 1000 MG Oral Granules
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ASPRUZYO SPRINKLERANOLAZINESUN PHARMACEUTICAL INDUSTRIES, INC.dd9f81e4-50da-4551-aed5-559d304df42e2025-01-29Warnings, Adverse reactionsExact identifier
rxcui: 2594759

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dd9f81e4-50da-4551-aed5-559d304df42eASPRUZYO Sprinkle 1000 MG Oral Granules [PSN] · ranolazine 1000 MG Oral Granules [Aspruzyo] [SBD] · Aspruzyo 1000 MG Oral Granules [SY] · Aspruzyo Sprinkle 1 GM Oral Granules [SY] · Aspruzyo Sprinkle 1000 MG Oral Granules [SY]53These highlights do not include all the information needed to use ASPRUZYO SPRINKLE safely and effectively. See full prescribing information for ASPRUZYO SPRINKLE. ASPRUZYO SPRINKLE TM (ranolazine) extended-release granules, for oral use Initial U.S. Approval: 200620250129